About

Log in?

DTU users get better search results including licensed content and discounts on order fees.

Anyone can log in and get personalized features such as favorites, tags and feeds.

Log in as DTU user Log in as non-DTU user No thanks

DTU Findit

Journal article

How Synthetic Biology and Metabolic Engineering Can Boost the Generation of Artificial Blood Using Microbial Production Hosts

From

Technical University of Denmark1

Eukaryotic Molecular Cell Biology, Section for Synthetic Biology, Department of Biotechnology and Biomedicine, Technical University of Denmark2

Network Engineering of Eukaryotic Cell factories, Section for Synthetic Biology, Department of Biotechnology and Biomedicine, Technical University of Denmark3

Section for Synthetic Biology, Department of Biotechnology and Biomedicine, Technical University of Denmark4

Department of Biotechnology and Biomedicine, Technical University of Denmark5

Innovation Project Leaders, Translational Management, Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark6

Pre-Pilot Plant, Translational Management, Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark7

Research Groups, Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark8

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark9

DTU Fermentation Platform, Section for Synthetic Biology, Department of Biotechnology and Biomedicine, Technical University of Denmark10

...and 0 more

Hemoglobin is an essential protein to the human body as it transports oxygen to organs and tissues through the bloodstream (Looker et al., 1992). In recent years, there has been an increasing concern regarding the global supply of this vital protein, as blood availability cannot currently meet the high demands in many developing countries.

There are, in addition, several risks associated with conventional blood transfusions such as the presence of blood-borne viruses like HIV and Hepatitis. These risks along with some limitations are presented in Figure 1 (Kim and Greenburg, 2013; Martínez et al., 2015). As an alternative, producing hemoglobin recombinantly will eliminate the obstacles, since hemoglobin-based oxygen carriers are pathogen-free, have a longer shelf-life, are universally compatible and the supply can be adjusted to meet the demands (Chakane, 2017).

A stable, safe, and most importantly affordable production, will lead to high availability of blood to the world population, and hence reduce global inequality, which is a focus point of the World Health Organization for the millennium (WHO, 2018). Synthetic biology and metabolic engineering have created a unique opportunity to construct promising candidates for hemoglobin production (Liu et al., 2014; Martínez et al., 2016).

This review sets out to describe the recent advances in recombinant hemoglobin production, the societal and the economic impact along with the challenges that researchers will face in the coming years, such as low productivity, degradation, and difficulties in scale-up. The challenges are diverse and complex but with the powerful tools provided by synthetic biology and metabolic engineering, they are no longer insurmountable.

An efficient production of cell-free recombinant hemoglobin poses tremendous challenges while having even greater potential, therefore some possible future directions are suggested in this review.

Language: English
Publisher: Frontiers Media S.A.
Year: 2018
Pages: 186
ISSN: 22964185
Types: Journal article
DOI: 10.3389/fbioe.2018.00186
ORCIDs: Martinez, José L.

DTU users get better search results including licensed content and discounts on order fees.

Log in as DTU user

Access

Analysis